Pneumonia, Ventilator-Associated: all 405 studies

Page 4 of 5. Open to participants first (85), then studies with results posted, then the rest; newest registration first within each.

• Weekly Versus no Routine Ventilator Circuit Changes in NICUTerminatedNCT02326207Not applicable
• Oral Care as a Preventive Measure of VAP; Miswak Versus Chlorhexidine and Toothbrush.CompletedNCT02288390Not applicable
• Biofilm Formation on Different Endotracheal Tube MaterialsCompletedNCT02284438Not applicable
• Diagnostic Value of Lung Ultrasound for Ventilator-Associated PneumoniaCompletedNCT02244723
• Occurrence of Ventilator Associated Pneumonia in Italian ICU Using Cuffed Tracheostomy Tubes With Subglottic Secretion DrainageCompletedNCT02223988Not applicable
• The Impact of Simultaneous Presence of Viral and Bacterial Pathogens on Therapy and Course of Severe PneumoniaStatus unknownNCT02203110
• Antibiotherapy During Therapeutic Hypothermia to Prevent Infectious ComplicationsCompletedNCT02186951Phase 3
• Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative BacteriaWithdrawnNCT02134106Phase 2/3
• Empiric Antibiotic Therapy for Ventilator-acquired Pneumonia With Gram-negative Bacilli in Intensive CareStatus unknownNCT02127528
• Oropharyngeal Administration of Mother's Colostrum for Premature Infants (NS-72393-360)CompletedNCT02116699Not applicable
• Pharmacokinetics, Safety and Efficacy of POL7080 in Patients With Ventilator Associated Pseudomonas Aeruginosa PneumoniaCompletedNCT02096328Phase 2
• Biomarkers in Patients Undergoing Mechanical VentilationCompletedNCT02078999
• Methods of Chlorhexidine Cleansing to Prevent Ventilator-Associated Pneumonia (VAP)CompletedNCT02077920Phase 2
• Errors in Prescription Antibiotics in Ventilator-associated PneumoniaStatus unknownNCT02074033
• Prevention Ventilator Associated PneumoniaCompletedNCT02060045Not applicable
• Air-impingement Manipulation to Clear Subglottic Secretion Compared With Drainage Tube in Prolonged Intubated PatientsStatus unknownNCT02032849Not applicable
• Clinical and Biological Markers in Acute Respiratory FailureCompletedNCT02019095
• Efficacy Study of Colistimethate Sodium Inhalation in Patients With Ventilator-associated PneumoniaTerminatedNCT01975350
• Biomarker-based Exclusion of VAP for Improved Antibiotic StewardshipCompletedNCT01972425Not applicable
• Impact of Tracheal Cuff Shape on Microaspiration in Intensive Care UnitsCompletedNCT01948635Not applicable
• Common Canister Protocol for Inhaler Administration in Mechanically Ventilated PatientsCompletedNCT01935388Phase 4
• Prehospital Ventilator-Associated Pneumonia Prevention TrialCompletedNCT01902446
• Prospective Observational Pilot-study for the Evaluation of the Nephro- an Neurotoxicity in the Anti-infectious Therapy With Inhalative Colistin Therapy for Patients With Ventilator-associated Pneumonia (VAP)CompletedNCT01894347
• Chlorhexidine Gluconate for Prevention of Ventilator Associated Pneumonia in Children.Status unknownNCT01883596Phase 4
• Can we Better Understand the Development of VAP and Eventually Predict and Prevent it?CompletedNCT01875692
• The Effect of Ulinastatin on Bronchoalveolar Lavage Fluid of Inflammatory Factors in Patients With Ventilator-associated PneumoniaStatus unknownNCT01865266Phase 2/3
• Comparison of Two Strategies of Oropharyngeal and Tracheal Suctioning in Mechanically Ventilated PatientsCompletedNCT01807884Not applicable
• Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired InfectionsStatus unknownNCT01798537Phase 2/3
• Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial (PROSPECT): A Feasibility Clinical TrialCompletedNCT01782755Phase 2
• Bronchial Colonization With Fungi and Late Respiratory Acquired PneumoniaCompletedNCT01770015Not applicable
• Impact of the Contamination Mode on the Clinical Evolution During Pseudomonas Aeruginosa Ventilator Acquired Pneumonia (PYO GEN)CompletedNCT01745796
• Implementation and Evaluation of Revised Protocols for Oral Hygiene for Mechanically Ventilated PatientsCompletedNCT01657396Not applicable
• CDC Prevention Epicenters Wake Up and Breathe CollaborativeCompletedNCT01583413Not applicable
• Colistin and Rifampicin for MDR-AcinetobacterCompletedNCT01577862Phase 3
• Early-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic TreatmentCompletedNCT01559753Phase 4
• Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic StrokeStatus unknownNCT01550419Early Phase 1
• Ventilator-associated Pneumonia (VAP) and Humidification SystemStatus unknownNCT01546974Phase 4
• Ventilator Associated Pneumonia in Taper Guard Versus Normal Tube in ICU PatientsStatus unknownNCT01501227Phase 4
• The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated PneumoniaCompletedNCT01489124Phase 4
• Toothbrushing and Ventilator-associated PneumoniaCompletedNCT01477099Phase 4
• The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated PneumoniaCompletedNCT01467648Phase 4
• Diagnostic Value of sTREM-1 and PCT Level as Well as CPIS Score for Ventilator-Associated Pneumonia Among ICU Sepsis PatientsCompletedNCT01406951
• Futility of Exhaled Breath Condensate pH Measurements in Ventilated Patients in Intensive Care Unit (ICU)TerminatedNCT01393431
• Pharmacodynamics Study of Imipenem in Patients With Ventilator Associated PneumoniaCompletedNCT01379157Phase 4
• Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated PneumoniaStatus unknownNCT01356472Phase 4
• Probiotics for Prevention of Ventilator-Associated Pneumonia (VAP)Status unknownNCT01301131Phase 4
• Evaluating the Effectiveness of the Tongue Cleaner in Critical PatientsCompletedNCT01294943
• Optimal Endotracheal Cuff Pressure During Hospitalization in Intensive Care Units Using AnapnoGuard 100 SystemCompletedNCT01188122Not applicable
• Effects of Airway Conditioning Devices on Ventilator Associated Pneumonia:a Randomized Clinical TrialCompletedNCT01150864Not applicable
• The Gravity-VAP (Ventilator-Associated Pneumonia) TrialTerminatedNCT01138540Phase 3
• Frequency of Ventilator Associated Pneumonia (VAP) in Mechanically Ventilated Patients Using the AnapnoGuard SystemCompletedNCT01126320Not applicable
• Intubation and Extubation Over 48 Hours Mechanical VentilationStatus unknownNCT01123681
• Antibiotic Prophylaxis for Early Ventilator-associated Pneumonia in Neurological PatientsWithdrawnNCT01118403Phase 4
• Removing Fluid Above Breathing Tubes in the Operating RoomCompletedNCT01110109
• Chlorhexidine vs Lactobacillus Plantarum for Oral Care in Intubated ICU PatientsCompletedNCT01105819Not applicable
• Oral Care Interventions and Ventilator Associated Pneumonia in Critically Ill ChildrenCompletedNCT01083407Phase 1
• STATIN-VAP STATIN-VAP - STATINs and Ventilator-Associated PneumoniaTerminatedNCT01057758Phase 3
• Direct E-test on Bronchoalveolar Lavage From Patients With Ventilator-acquired PneumoniaCompletedNCT01042353Phase 4
• Cost Effectiveness Of Linezolid In Central AmericaWithdrawnNCT01040585
• Serial Changes in sTREM-1 During Ventilator-associated Pneumonia (VAP)CompletedNCT00976157
• Impact of Imipenem With Amikacin Pharmacokinetic and PharmacodynamicCompletedNCT00950222Not applicable
• Study of Povidone Iodine to Reduce Pulmonary Infection in Head Trauma and Cerebral Hemorrhage in Intensive Care UnitTerminatedNCT00950027Phase 3
• Study to Determine Quicker Methods of Diagnosing Pneumonia Caused by a Breathing Machine in Critically Ill PatientsCompletedNCT00938002
• Ventilator-Associated Pneumonia (VAP) in Intensive Care Unit (ICU)Status unknownNCT00935285
• Study Assessing Immunogenicity and Safety of IC43 In Intensive Care PatientsCompletedNCT00876252Phase 2
• Pharmacokinetics of Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical VentilationStatus unknownNCT00861315Phase 2/3
• Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas AeruginosaCompletedNCT00851435Phase 1/2
• Effectiveness of Dental Brushing for Preventing Ventilator-Associated PneumoniaStatus unknownNCT00842478Phase 2/3
• Oral Hygiene With Chlorhexidine and Incidence of Ventilator-Associated Pneumonia in Children Submitted to Heart SurgeryCompletedNCT00829842Phase 3
• Nebulized Ceftazidime and Amikacin in Ventilator Associated PneumoniaCompletedNCT00786305Phase 2
• Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated PneumoniaTerminatedNCT00771719Phase 1
• Serum Procalcitonin Study in the Management of Ventilated PatientsCompletedNCT00726167
• A Clinico-Bacteriological Study and Effect of Stress Ulcer Prophylaxis on Occurrence of Ventilator Associated PneumoniaCompletedNCT00702871Phase 4
• Pravastatin and Ventilatory Associated PneumoniaCompletedNCT00702130Early Phase 1
• Pilot Trial of KB001 in Mechanically-Ventilated Patients Colonized With Pseudomonas AeruginosaCompletedNCT00691587Phase 1/2
• Lactobacillus GG in the Prophylaxis of Ventilator Associated PneumoniaCompletedNCT00613795Phase 3
• Azithromycin as a Quorum-Sensing Inhibitor for the Prevention of Pseudomonas Aeruginosa Ventilator-Associated PneumoniaTerminatedNCT00610623Phase 2
• Effect of Oral Decontamination Using Chlorhexidine or Potassium Permanganate in ICU PatientsCompletedNCT00610324Phase 4
• Oral Care Protocol for Preventing Ventilator- Associated PneumoniaCompletedNCT00604916Early Phase 1
• Role of Oral Chlorhexidine Gel in Prevention of Ventilator Associated PneumoniaCompletedNCT00597688Phase 3
• Bronchoscopy vs. Clinical Pulmonary Infection Score Guided Approach in Suspected Ventilator-Associated Pneumonia (VAP)WithdrawnNCT00588588Phase 3
• Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus AureusCompletedNCT00572559Phase 4
• Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated PneumoniaTerminatedNCT00543608Phase 2
• Prophylaxis of Ventilator Associated Pneumonia by Continuous Lateral Rotation TherapyCompletedNCT00529776Not applicable
• Comparison Between Two Methods of Oral Care on the Incidence of VAPCompletedNCT00521677Not applicable
• Effects of Oral Care in the Neuroscience ICUCompletedNCT00518752Not applicable
• The Diagnostic and Prognostic Utility of Procalcitonin (ProCT) for Ventilator-associated Pneumonia (VAP)TerminatedNCT00498121
• Diagnosis of Ventilator- Associated Pneumonia in Children: A Comparative Study of Bronchoscopic and Non-Bronchoscopic MethodsCompletedNCT00495963Phase 3
• Effect of Gravity on Tracheal Colonization During Mechanical Ventilation in InfantsCompletedNCT00491660Not applicable
• A Multi-Center Observational Surveillance Study of VAP Causing BacteriaCompletedNCT00484588
• Endotracheal Tube With Polyurethane Cuff and Subglottic Secretion DrainageCompletedNCT00475579Phase 4
• The Effect of Intensive Insulin TherapyCompletedNCT00447239Not applicable
• Time Interval for Changing Closed System Suction Catheters, Effect on Ventilator Associated PneumoniaCompletedNCT00447109Not applicable
• Study of Knowledge Translation of Clinical Practice Guidelines for Ventilator Associated PneumoniaCompletedNCT00434460
• Saline Instillation Before Tracheal Suctioning and the Incidence of Ventilator Associated PneumoniaCompletedNCT00432718Not applicable
• Aerosolized Antibiotics and Respiratory Tract Infection in Patients on Mechanical VentilationCompletedNCT00396578Phase 2
• Prevention of Ventilator-Associated Pneumonia by Automatic Control of the Tracheal Tube Cuff PressureCompletedNCT00364299Not applicable
• Ontario ICU Clinical Best Practices Demonstration ProjectCompletedNCT00332982Not applicable
• Intravenous Clarithromycin in Septic SyndromeCompletedNCT00297674Phase 4
• Strategies to Prevent Pneumonia (SToP Pneumonia)CompletedNCT00234598Phase 2

← Pneumonia, Ventilator-Associated overview